THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA

DSpace/Manakin Repository

Title:	THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA
Author:	Wood, Valerie D.
Citation:	THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA (1995 Third Year Paper)
Full Text & Related Files:	vwood2.pdf (177.2Kb; PDF) vwood2.rtf (43.98Kb; RTF file) vwood2.html (48.24Kb; HTML)
Abstract:	Section 704 of the Federal Food, Drug and Cosmetic Act authorizes the Food and Drug Administration to conduct inspections of regulated business establishments. In the statute. Congress required that the inspections be at reasonable times and within reasonable limits and in a reasonable manner. Congress further restricted the inspections from including general financial and personnel data, and research data not relating to specially regulated drugs.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889438
Downloads of this work: